-
Salinomycin Workflows for HCC Research
2026-08-26
Build reproducible hepatocellular carcinoma assays around Salinomycin’s ion-transport, apoptosis, calcium, and Wnt/β-catenin effects. This practical guide connects dose-response design with orthogonal validation, controls for ionophore-specific artifacts, and translates animal-to-cell toxicity insights without overstating clinical readiness.
-
Pronase E for Proteomics in Ferroptosis Research
2026-08-26
Pronase E is a broad-spectrum protease mixture for protein sample preparation, peptide mapping, and proteomics. This article shows how its analytical strengths can support, but not replace, orthogonal assays used to study gramine-driven ferroptosis in triple-negative breast cancer.
-
Ibotenic Acid Toxicity in Mice: Dose and Time Effects
2026-08-25
A 2026 study in Toxin Reviews provides a time-resolved in vivo analysis of ibotenic acid toxicity in mice, linking behavioral changes and blood biochemical disturbances with early c-fos activation and later loss of Nissl bodies. Its dose comparison helps distinguish transient neurobehavioral effects from severe, potentially fatal toxicity and informs the responsible interpretation of ibotenic acid-based neuroscience models.
-
Thymoquinone: Mechanisms and Cardiotoxicity Evidence
2026-08-25
Thymoquinone, also known as 2-isopropyl-5-methylcyclohexa-2,5-diene-1,4-dione, is a quinone phytochemical used as a biomedical research probe. Preclinical evidence indicates that it protects mouse hearts from doxorubicin-associated injury through Nrf2/HO-1 activation, antioxidant responses, and reduced ferroptosis.
-
MTT Assay Workflows for Cell Viability Research
2026-08-24
Use MTT to convert viable-cell metabolism into a practical colorimetric endpoint for proliferation, cytotoxicity, and gene-perturbation studies. This guide pairs a reproducible workflow with interpretation safeguards for research such as miR-519d–Rab10 signaling in hepatocellular carcinoma.
-
GLP-1 (9-36) Amide for GPCR Assay Design
2026-08-24
GLP-1 (9-36) amide enables rigorous glucagon-like peptide-1 receptor antagonist experiments beyond simple pathway inhibition. This guide translates receptor crosstalk findings into practical assay controls, interpretation rules, and peptide-handling decisions for metabolic research.
-
Gastric Cancer Assembloids Model Tumor–Stroma Biology
2026-08-23
Shapira-Netanelov and colleagues developed patient-derived gastric cancer assembloids that combine tumor organoids with matched stromal cell subpopulations from the same tissue. The model reproduced clinically relevant tumor–stroma signaling and revealed that stromal composition can reshape gene expression and drug sensitivity, supporting more physiologically informed personalized testing.
-
Moxidectin–Polyenes Against Oral Candidiasis
2026-08-22
A 2024 study shows that moxidectin potentiates amphotericin B and Nystatin by increasing Candida albicans ergosterol biosynthesis, thereby strengthening polyene binding and antifungal activity. The combination suppressed fungal growth, biofilms, and oral infection in mice, while ergosterol-pathway mutants helped establish the mechanism.
-
Calpeptin: From Calpain Biology to Translation
2026-08-22
Calpeptin offers translational researchers a way to interrogate calcium-dependent cysteine protease biology across fibrosis, inflammation, and extracellular vesicle research. This article connects its nanomolar calpain 1 potency with pulmonary fibrosis evidence and the extracellular-vesicle findings of McNamee et al., while outlining practical controls, study limitations, and a strategy for moving from pathway modulation to mechanism-led validation.
-
TCF25, Lysosomal Acidification, and Cell Death
2026-08-21
Ren et al. identify TCF25 as a nutrient sensor that increases V-ATPase-dependent lysosomal acidification during glucose starvation. The study reveals a time-dependent switch from protective autophagy and ATP generation to ferritinophagy-associated lysosomal membrane permeabilization and lysosome-dependent cell death, with implications for metabolic stress and hepatic ischemia-reperfusion injury.
-
Dual Luciferase Assay System for Reliable Readouts
2026-08-20
Learn how the Dual Luciferase Assay System, SKU K1136, addresses normalization, compatibility, and workflow challenges in mammalian reporter experiments. This scenario-based guide connects dual-reporter design with gene expression regulation, BMSC osteogenesis research, and practical vendor selection.
-
OCT2 and MATE1 Inhibition by 5-HT3 Antagonists
2026-08-20
George and colleagues systematically compared five 5-HT3 antagonists for inhibition of renal OCT2 and MATE1, combining transporter-specific uptake assays with a polarized epithelial transport model. The results identify distinct potency patterns, with ondansetron showing particularly strong MATE1 inhibition and palonosetron showing strong OCT2 inhibition, supporting a mechanistic basis for possible cationic drug–drug interactions.
-
SP600125: A Practical JNK Assay Guide
2026-08-19
Learn how SP600125, SKU A4604, can help researchers separate JNK-dependent signaling from nonspecific viability and cytotoxicity effects. This scenario-based guide covers assay compatibility, solubility, dosing, interpretation, and practical supplier-selection criteria.
-
From Wnt Biology to Cy3 Colitis Imaging
2026-08-19
Mechanistic studies of curcumin in DSS-induced colitis show why spatially resolved protein detection matters: Wnt/β-catenin regulation, SOX9-associated signaling, and intestinal stem cell differentiation must be interpreted in tissue context. This thought-leadership guide explains how a Cy3-conjugated secondary antibody can strengthen translational immunofluorescence workflows while addressing controls, storage, assay design, competitive approaches, and the limitations of moving from preclinical imaging to clinical relevance.
-
How p38α Conformation Shapes Dephosphorylation
2026-08-18
A bioRxiv study shows that some kinase inhibitors can do more than block p38α catalytic activity: they can also expose the activation-loop phosphothreonine to the WIP1 phosphatase. The structural and biochemical findings introduce kinase conformation as a strategy for improving the specificity and durability of p38α pathway inhibition.